CVS Health (CVS) Stock Price & Analysis
CVS Stock Chart & Stats
- Day’s Range
- MXN 1,700.00 - MXN 1,704.00
- 52-Week Range
- MXN 1,200.00 - MXN 2,000.00
- Previous Close
- MXN 1,700.00
- Volume
- 13
- Average Volume (3M)
- 714
- Market Cap
- MXN 2.17T
- Enterprise Value
- MXN 195.69B
- Total Cash (Recent Filing)
- MXN 13.96B
- Total Debt (Recent Filing)
- MXN 76.31B
- Price to Earnings (P/E)
- 23.6
- Beta
- 0.02
- Next Earnings
- Nov 04, 2026 (Est.)
- EPS Estimate
- 31.06
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 2.92%
Bulls Say, Bears Say
Bulls Say
Cash Generation And Deleveraging
Strong and improving cash generation gives CVS greater capacity to fund operations, reduce debt, and invest in healthcare capabilities. The concurrent deleveraging trend improves financial flexibility and provides a more durable foundation for managing reimbursement or utilization pressure.
Health Services Growth
Caremark and related Health Services operations are showing meaningful revenue and profit growth, supported by purchasing economics, pharmacy mix, and specialty performance. Continued scale in these services can strengthen CVS’s integrated platform and support earnings resilience.
Specialty Pharmacy Advantage
Consistently higher adherence indicates a meaningful operational and technology advantage in specialty pharmacy, where outcomes and therapy persistence are important. This capability can support client retention, improve patient results, and reinforce CVS’s position in a structurally growing care category.
Bears Say
Compressed Profitability
Very thin and reduced margins leave CVS with limited earnings cushion when medical costs, reimbursement, or operating expenses increase. Although revenue remains large, weaker profitability and depressed returns indicate that scale is not currently translating into consistently strong economic efficiency.
340B Program Pressure
Ongoing 340B pressure can weigh on pharmacy economics beyond a single quarter because the program environment and manufacturer restrictions affect how related services are priced and reimbursed. The unresolved headwind could limit margin recovery and complicate forward earnings planning.
Caremark Membership Decline
Lower Caremark membership could reduce the scale supporting CVS’s purchasing, claims-processing, and benefit-management economics. Even disciplined client selection may create a period of revenue and volume pressure, while product exits and weaker retention make future growth less predictable.
CVS FAQ
What was CVS Health’s price range in the past 12 months?
What is CVS Health’s market cap?
When is CVS Health’s upcoming earnings report date?
How were CVS Health’s earnings last quarter?
Is CVS Health overvalued?
Does CVS Health pay dividends?
What is CVS Health’s EPS estimate?
How many shares outstanding does CVS Health have?
What happened to CVS Health’s price movement after its last earnings report?
Which hedge fund is a major shareholder of CVS Health?
What is the TipRanks Smart Score and how is it calculated?
CVS Health Stock Smart Score
Company Description
CVS Health
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- J. David Joyner
- Employees
- 259,500
- Website
- www.cvshealth.com
- Address
- One CVS Drive, Woonsocket, RI, 02895, US
CVS Health (CVS) Earnings & Revenues
CVS Company Deck
CVS Earnings Call
Earnings Call SentimentPositive
The call conveyed strong operational and financial momentum across segments with material upside: double-digit growth in operating income, raised EPS guidance, improved cash flow outlook, specialty leadership, and early tangible AI-driven efficiencies. Offsetting these positives are notable industry-specific headwinds—most prominently near-term 340B pressures, anticipated Caremark membership declines in 2027, ongoing reimbursement and regulatory pressures, and some timing-related pull-forwards. Management emphasized disciplined execution, balance sheet improvement and a multi-year growth outlook (mid-teens EPS CAGR through 2028), while acknowledging and preparing for specific near-term headwinds.
View all MX:CVS earnings summariesCVS Net sales Breakdown
- 46.57% Health Services
- 35.05% Health Care Benefits
- 33.40% Pharmacy & Consumer Wellness
- 0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 5 | 2 |
| Technical Analysis | 5 | 5 | 0 |
| Moving Averages | 10 | 0 | 2 |
